184 related articles for article (PubMed ID: 26988030)
1. Glycoprotein nonmetastatic melanoma protein B extracellular fragment shows neuroprotective effects and activates the PI3K/Akt and MEK/ERK pathways via the Na+/K+-ATPase.
Ono Y; Tsuruma K; Takata M; Shimazawa M; Hara H
Sci Rep; 2016 Mar; 6():23241. PubMed ID: 26988030
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein nonmetastatic melanoma protein B (GPNMB) promotes the progression of brain glioblastoma via Na
Ono Y; Chiba S; Yano H; Nakayama N; Saio M; Tsuruma K; Shimazawa M; Iwama T; Hara H
Biochem Biophys Res Commun; 2016 Dec; 481(1-2):7-12. PubMed ID: 27836549
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia-reperfusion injury.
Nakano Y; Suzuki Y; Takagi T; Kitashoji A; Ono Y; Tsuruma K; Yoshimura S; Shimazawa M; Iwama T; Hara H
Neuroscience; 2014 Sep; 277():123-31. PubMed ID: 25010402
[TBL] [Abstract][Full Text] [Related]
4. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF.
Li Y; Yuan S; Liu J; Wang Y; Zhang Y; Chen X; Si W
J Cell Physiol; 2020 Mar; 235(3):2071-2079. PubMed ID: 31347172
[TBL] [Abstract][Full Text] [Related]
5. GPNMB promotes peripheral nerve regeneration by activating the Erk1/2 and Akt pathways via binding Na
Huang C; Zheng Y; Ji R; Qiao L; Zhang X; Lin H; Liu F; Xu J; Li Y; Zhang Z; Yang X
Exp Neurol; 2024 Mar; 373():114687. PubMed ID: 38199512
[TBL] [Abstract][Full Text] [Related]
6. Na+/K+‑ATPase DR region‑specific antibody protects U251 cells against hypoxia reperfusion‑induced injury via the PI3K/AKT and ERK pathways.
Gong H; Lü P; Zhang J; Li D; Zheng J; Song J
Mol Med Rep; 2017 Dec; 16(6):7901-7906. PubMed ID: 28983584
[TBL] [Abstract][Full Text] [Related]
7. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
8. α-Lipoic acid attenuates oxidative stress and neurotoxicity via the ERK/Akt-dependent pathway in the mutant hSOD1 related Drosophila model and the NSC34 cell line of amyotrophic lateral sclerosis.
Wang T; Cheng J; Wang S; Wang X; Jiang H; Yang Y; Wang Y; Zhang C; Liang W; Feng H
Brain Res Bull; 2018 Jun; 140():299-310. PubMed ID: 29842900
[TBL] [Abstract][Full Text] [Related]
9. Expression of glycoprotein nonmetastatic melanoma protein B in macrophages infiltrating injured mucosa is associated with the severity of experimental colitis in mice.
Sasaki F; Kumagai K; Uto H; Takami Y; Kure T; Tabu K; Nasu Y; Hashimoto S; Kanmura S; Numata M; Moriuchi A; Sakiyama T; Tsubouchi H; Ido A
Mol Med Rep; 2015 Nov; 12(5):7503-11. PubMed ID: 26458492
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection induced by Na(+)/K(+)-ATPase activation involves extracellular signal-regulated kinase 1/2 and phosphoinositide 3-kinase/Akt pathway.
Zheng J; Koh X; Hua F; Li G; Larrick JW; Bian JS
Cardiovasc Res; 2011 Jan; 89(1):51-9. PubMed ID: 20724308
[TBL] [Abstract][Full Text] [Related]
11. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
[TBL] [Abstract][Full Text] [Related]
13. Periplocin promotes wound healing through the activation of Src/ERK and PI3K/Akt pathways mediated by Na/K-ATPase.
Chen L; Jiang P; Li J; Xie Z; Xu Y; Qu W; Feng F; Liu W
Phytomedicine; 2019 Apr; 57():72-83. PubMed ID: 30668325
[TBL] [Abstract][Full Text] [Related]
14. ApoSOD1 lacking dismutase activity neuroprotects motor neurons exposed to beta-methylamino-L-alanine through the Ca
Petrozziello T; Secondo A; Tedeschi V; Esposito A; Sisalli M; Scorziello A; Di Renzo G; Annunziato L
Cell Death Differ; 2017 Mar; 24(3):511-522. PubMed ID: 28085149
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
[TBL] [Abstract][Full Text] [Related]
17. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
18. MAPK Pathway Inhibitors Sensitize BRAF-Mutant Melanoma to an Antibody-Drug Conjugate Targeting GPNMB.
Rose AA; Annis MG; Frederick DT; Biondini M; Dong Z; Kwong L; Chin L; Keler T; Hawthorne T; Watson IR; Flaherty KT; Siegel PM
Clin Cancer Res; 2016 Dec; 22(24):6088-6098. PubMed ID: 27515299
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
Ripple MO; Kalmadi S; Eastman A
Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway.
Ivanov VN; Hei TK
Oncogene; 2005 Jan; 24(4):616-26. PubMed ID: 15580309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
